Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627575 · ClinicalTrials.gov registry record · Phase 1
AED/Statin Interaction Study
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 119
- Enrollment target
NCT00627575: Completed Phase 1 study, sponsored by GlaxoSmithKline.
NCT00627575 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 119 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00627575, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 119 participants
- Enrollment target
Study Summary
This study will evaluate the amount of the cholesterol-lowering drug atorvastatin available in the bloodstream, when taken together with the anti-seizure drugs lamotrigine or phenytoin.
Primary Outcome
Steady-state Cmax and AUC (0-t) of atorvastatin when dosed to steady-state.
Interventions
- DRUG atorvastatin
- DRUG lamotrigine
- DRUG phenytoin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2008-02-04 |
| Est. Completion | 2008-09-12 |
| Phase | Phase 1 |
What the finished NCT00627575 record still lists
NCT00627575 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% higher).
The record links to 0 conditions, and to 3 interventions - of which atorvastatin is the first listed.
NCT00627575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00627575 about?
NCT00627575 is a clinical study titled "AED/Statin Interaction Study". This study will evaluate the amount of the cholesterol-lowering drug atorvastatin available in the bloodstream, when taken together with the anti-seizure drugs lamotrigine or phenytoin.
What is the current status of trial NCT00627575?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 119 participants. The study started on 2008-02-04. Estimated completion is 2008-09-12.
What interventions are being tested in trial NCT00627575?
The interventions under investigation include: atorvastatin (DRUG), lamotrigine (DRUG), phenytoin (DRUG).
Who is sponsoring clinical trial NCT00627575?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00627575's enrollment target sits among peer trials
119 498th of 2000 higher than 1,502 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI